Invention Grant
- Patent Title: Composition for culturing NK cells and method for culturing NK cells using same
-
Application No.: US16645215Application Date: 2018-11-20
-
Publication No.: US11746327B2Publication Date: 2023-09-05
- Inventor: Hee Jung An , Yeon Ho Choi , Eun Jin Lim , Yong Wha Moon , Se Wha Kim
- Applicant: SUNGKWANG MEDICAL FOUNDATION
- Applicant Address: KR Seoul
- Assignee: SUNGKWANG MEDICAL FOUNDATION
- Current Assignee: SUNGKWANG MEDICAL FOUNDATION
- Current Assignee Address: KR Seoul
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: KR 20170158577 2017.11.24
- International Application: PCT/KR2018/014294 2018.11.20
- International Announcement: WO2019/103436A 2019.05.31
- Date entered country: 2020-03-06
- Main IPC: C12N5/0783
- IPC: C12N5/0783 ; A61P35/00 ; A61K35/17

Abstract:
Provided are a composition for culturing NK cells, and a method of culturing NK cells using the same. According to an aspect, in culturing NK cells from peripheral blood mononuclear cells, when NK cells are cultured in a medium including the composition for culturing NK cells, the composition including IL-15, IL-18, and IL-27, the NK cells may proliferate in large quantities and activation of NK cells may be promoted. Therefore, when the NK cells are used, cancer cell apoptosis or cancer cell-killing ability may be promoted. Accordingly, the NK cells may be used as an effective adoptive immune cell therapy product in cancer prevention or treatment.
Public/Granted literature
- US20210095249A1 COMPOSITION FOR CULTURING NK CELLS AND METHOD FOR CULTURING NK CELLS USING SAME Public/Granted day:2021-04-01
Information query